The levels of cerebrospinal fluid in Aβ fragments and of hyperphosphorylated or total tau protein are the most widely used diagnostic biomarkers; however, early diagnosis of AD type dementia is still a challenging task (Nakamura et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.